BriaCell Therapeutics Corp. (BCTX)
NASDAQ
3.92
-0.08 (-2.00%)
Closed
Oct 8, 2026
Day's Range
3.874.05
52 wk Range
2.6014.68
Financial Statements - BCTX - BriaCell Therapeutics Corp.
Revenue
0
Net Income
-4.93M▲ 75.7%
EBITDA
-33.06M▼ 30.5%
Free Cash Flow
-24.58M▼ 3.5%
Income Statement
| Period Ending | 2025-07-31 | 2024-07-31 | 2023-07-31 | 2022-07-31 | 2021-07-31 | 2020-07-31 |
|---|---|---|---|---|---|---|
| Sales | - | 0 | 0 | 0 | 0 | 0 |
| Cost of Goods | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | - | -33.33M | -23.27M | -15.28M | -6.97M | -2.76M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | 28.11M | 2.07M | -11.68M | -6.76M | -55.62K |
| Pre Tax Income | - | -4.93M | -20.30M | -26.83M | -13.81M | -2.83M |
| Income Tax | - | - | - | - | - | - |
| Net Income | - | -4.93M | -20.30M | -26.83M | -13.81M | -2.83M |
| EPS Basic | -62.19 | -43.68 | -1.3 | -1.73 | -0.09 | -5.64 |
| EPS Diluted | -62.19 | -43.68 | -1.3 | -1.73 | -0.09 | -5.64 |
| Basic Shares Outstanding | 423.11K | 109.69K | 15.61M | 15.49M | 4.51M | 713.88K |
| Diluted Shares Outstanding | 423.11K | 109.69K | 15.61M | 15.49M | 4.51M | 713.88K |
| Ebit | - | -4.93M | -23.27M | -26.83M | -13.73M | -2.81M |
| Ebitda | - | -33.06M | -25.33M | -15.13M | -6.95M | -2.79M |
| Net Income Continuous Operations | - | -4.93M | -20.30M | -26.83M | -13.81M | -2.83M |
| Minority Interests | - | 140.08K | 0 | - | - | - |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
